All In Biotech

Drug Trial Radar · NCT07137598

A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)

A Phase II, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have an Inadequate Response or Intolerance to TNF and/or JAK Inhibitors

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

160

Planned (sponsor's estimate)

Start

Dec 5, 2025

Primary completion

Apr 17, 2027

Study completion Oct 2, 2027

Sponsor

Lead sponsor
Hoffmann-La RocheRoche (Genentech) (RHHBY)
Sponsor type
Industry
First posted
Aug 22, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, care provider, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will assess the efficacy and safety of Afimkibart (also known as RO7790121) compared with placebo in participants with moderate to severe rheumatoid arthritis (RA) who have an inadequate response or intolerance to TNF and/or JAK inhibitors.

Conditions

  • Rheumatoid Arthritis

Interventions

  • AfimkibartDrug

    Afimkibart will be administered as SC injection.

  • PlaceboDrug

    Placebo will be administered as SC injection.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in Disease Activity Score-28 for Rheumatoid Arthritis with C-Reactive Protein (DAS28-CRP)Time frame: Baseline, At Week 14

Locations

66 sites in 12 countries. Site status is shown where the registry gives one.

  • Arizona Arthritis & Rheumatology Associates, P.C.

    Avondale, Arizona · Recruiting

  • SunValley Arthritis Center Ltd.

    Peoria, Arizona · Recruiting

  • University of California Medical Center

    La Jolla, California · Recruiting

  • Cedars Sinai Medical Center

    Los Angeles, California · Recruiting

  • Inland Rheumatology Clinical Trials Incorporated

    Upland, California · Recruiting

  • West Broward Rheumatology Associates, Inc.

    Tamarac, Florida · Recruiting

  • Willow Rheumatology and Wellness PLLC

    Willowbrook, Illinois · Recruiting

  • Equity Medical

    Owensboro, Kentucky · Recruiting

  • Accurate Clinical Research Inc.

    Lake Charles, Louisiana · Recruiting

  • Louisiana State University Health Sciences Center New Orleans

    New Orleans, Louisiana · Recruiting

  • Henry Ford Medical Center- New Center One

    Detroit, Michigan · Recruiting

  • Equity Medical

    The Bronx, New York · Recruiting

  • Ohio State University Wexner Medical Center

    Columbus, Ohio · Recruiting

  • Altoona Center For Clinical Research

    Duncansville, Pennsylvania · Recruiting

  • Precision Comprehensive Clinical Research Solutions

    Colleyville, Texas · Recruiting

  • Accurate Clinical Management

    Houston, Texas · Recruiting

  • DM Clinical Research at Tomball

    Tomball, Texas · Recruiting

  • Tidewater Clinical Research

    Chesapeake, Virginia · Recruiting

  • Rheumatic Disease Center

    Glendale, Wisconsin · Recruiting

  • Centro Privado de Medicina Familiar - Mind Out Research

    Ciudad Autonoma Buenos Aires, Argentina · Recruiting

  • CER San Juan Centro Polivalente de Asistencia e Investigacion Clinica

    San Juan, Argentina · Recruiting

  • Centro Medico Arsema

    Ciudad Autnoma de Buenos Aires, Buenos Aires, Argentina · Recruiting

  • Centro de Investigaciones Medicas Mar Del Plata

    Mar del Plata, Buenos Aires, Argentina · Recruiting

  • APRILLUS Asistencia e Investigacion

    Buenos Aires, Ciudad Autonoma Buenos Aires, Argentina · Recruiting

  • Centro de Investigaciones Medicas Tucuman

    San Miguel de Tucumán, Tucumán Province, Argentina · Recruiting

  • HUB Erasme

    Brussels, Belgium · Recruiting

  • UZ Leuven

    Leuven, Belgium · Recruiting

  • L2IP ?Instituto de Pesquisas Clínicas Ltda.

    Brasília, Federal District, Brazil · Recruiting

  • IPC MT Instituto de Pesquisas Clinicas do Mato Grosso

    Cuiab, Mato Grosso, Brazil · Recruiting

  • Centro Mineiro de Pesquisa - CMIP

    Juiz de Fora, Minas Gerais, Brazil · Recruiting

  • Centro de Estudos em Terapias Inovadoras ? CETI

    Curitiba, Paraná, Brazil · Recruiting

  • Hospital So Lucas da PUCRS

    Porto Alegre, Rio Grande do Sul, Brazil · Recruiting

  • Hospital das Clínicas FMRP-USP

    Ribeirão Preto, São Paulo, Brazil · Recruiting

  • CEPIC - Centro Paulista de Investigao Clnica e Servios Mdicos

    So Paulo, São Paulo, Brazil · Recruiting

  • Bispebjerg og Frederiksberg Hospital

    Frederiksberg, Denmark · Recruiting

  • Sjllands Universitetshospital

    Køge, Denmark · Recruiting

  • Hpital Cochin

    Paris, France · Recruiting

  • CHU Strasbourg Hpital Hautepierre

    Strasbourg, Bas Rhin, France · Recruiting

  • Hopital de la Conception

    Marseille, Bouches-du-Rhne, France · Recruiting

  • Hopital Lapeyronie

    Montpellier, Herault, France · Recruiting

Showing 40 of 66 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.